10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0000946644-15-000013`
Period End Date	20150331
Filing Date	20150512
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	heb-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 31 Cash Flow Statement 48 Stockholders Equity 9

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.94M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$13.95M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$14.06M	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	$480.00K	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Inventory-work in process	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$399.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$432.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.92M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	225.74M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$16.51M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	204.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.80M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	225.74M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	204.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$935.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$861.00K	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	-	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.34M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$30.79M	USD	Point-in-time
Total assets	`Assets`	$29.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.08M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.32M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.49M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.33M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$15.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$22.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.44M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 225,737,722 and 204,004,818, respectively	`CommonStockValue`	$226.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 225,737,722 and 204,004,818, respectively	`CommonStockValue`	$204.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$302.73M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$308.01M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-49.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-160.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-277.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-281.21M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.97M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$30.79M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$29.44M	USD	Point-in-time

Income Statement 31 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$36.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$76.00K	USD	1 Quarter
Total revenues	`Revenues`	$76.00K	USD	1 Quarter
Total revenues	`Revenues`	$36.00K	USD	1 Quarter
Production costs	`CostOfRevenue`	$372.00K	USD	1 Quarter
Production costs	`CostOfRevenue`	$323.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.33M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.67M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.54M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.91M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$4.96M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$5.19M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.11M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.92M	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$3.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$2.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$106.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$153.00K	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.37M	USD	Point-in-time
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.44M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnInvestments`	$21.00K	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnInvestments`	$111.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.81M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.33M	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	213.63M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	176.73M	shares	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.44M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$167.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$180.00K	USD	1 Quarter
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$165.00K	USD	1 Quarter
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$71.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$88.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$58.00K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$480.00K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	-	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$33.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-25.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-16.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$236.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-844.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$512.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.26M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.90M	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$65.00K	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$145.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$75.00K	USD	1 Quarter
Sales and maturities of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Sales and maturities of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$37.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-192.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-177.00K	USD	1 Quarter
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$11.00K	USD	1 Quarter
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$7.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$6.38M	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$5.24M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.24M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.37M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$786.00K	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.30M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.94M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.94M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	-	USD	1 Quarter
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$38.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$111.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$21.00K	USD	1 Quarter
Cash paid for interest expense	`InterestPaid`	$2.00K	USD	1 Quarter
Cash paid for interest expense	`InterestPaid`	$3.00K	USD	1 Quarter

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.97M	USD	Point-in-time
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$58.00K	USD	1 Quarter
Stock sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$5.24M	USD	1 Quarter
Net comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-3.33M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.97M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.